Skip to main content
Premium Trial:

Request an Annual Quote

Harvard Bio Blames Service for Genomic Solutions IPO Gaffe

NEW YORK, May 24 (GenomeWeb News) - Genomic Solutions' parent company, Harvard Biosciences, said neither firm is responsible for the erroneous IPO filing attributed to the subsidiary yesterday.

 

"Contrary to media reports, neither Harvard Bioscience nor its wholly owned subsidiary, Genomic Solutions, yesterday filed a Form S-1 registration statement with the SEC," Harvard Bio said in its statement, which appeared more than one day after multiple news outlets reported that the unit had filed for an initial public offering.

 

"We believe the source of the error was a service that reports on SEC filings. Generally, we have a policy of not commenting on media reports or rumors, however we have made an exception to correct these erroneous reports," Harvard Bio said.

 

News services, including GenomeWeb News, yesterday updated their reports to reflect that Genomic Solutions erroneously refiled its initial public offering documents from 2000. It was originally reported that the subsidiary was moving ahead with the $100 million IPO registration. The registration forms were later removed from the SEC's web site.

 

A Genomic Solutions spokesman told Dow Jones earlier today that the forms it released were an "erroneous reissue." Harvard Bio's statement closes the saga.

 

Neither Genomic Solutions nor Harvard Bioscience returned GenomeWeb News' calls for comment.

The Scan

Genetic Tests Lead to Potential Prognostic Variants in Dutch Children With Dilated Cardiomyopathy

Researchers in Circulation: Genomic and Precision Medicine found that the presence of pathogenic or likely pathogenic variants was linked to increased risk of death and poorer outcomes in children with pediatric dilated cardiomyopathy.

Fragile X Syndrome Mutations Found With Comprehensive Testing Method

Researchers in Clinical Chemistry found fragile X syndrome expansions and other FMR1 mutations with ties to the intellectual disability condition using a long-range PCR and long-read sequencing approach.

Team Presents Strategy for Speedy Species Detection in Metagenomic Sequence Data

A computational approach presented in PLOS Computational Biology produced fewer false-positive species identifications in simulated and authentic metagenomic sequences.

Genetic Risk Factors for Hypertension Can Help Identify Those at Risk for Cardiovascular Disease

Genetically predicted high blood pressure risk is also associated with increased cardiovascular disease risk, a new JAMA Cardiology study says.